Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Diagnosis, Manifestations, & Outcomes Poster I
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Treatment Poster I
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Systemic Lupus Erythematosus – Animal Models Poster
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0084: DB-2304, an Immunomodulatory Antibody‒drug Conjugate (ADC) Targeting BDCA2, Displays Strong In Vivo Efficacy in Pharmacodynamic and Psoriasis Models
    Abstract Poster Presenter: Xi Li, PhD – Duailty Biologics
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0085: A Novel, Potent and Selective TLR7/8 Small Molecule Inhibitor Blocks TLR7/8 Pathway in the Presence of HCQ and Demonstrates Robust Preclinical Efficacy in Lupus Models
    Abstract Poster Presenter: Ching Shang, PhD – Gilead Sciences
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0086: Evaluating the Efficacyof B Cell Targeting Drug Candidates Using a Humanized BAFF Transgenic SLE Mouse Model
    Abstract Poster Presenter: Juan Liang, DrPH – Gempharmatech
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0087: SYNCAR: An Engineered IL-2/IL-2R-system That Selectively Enhances CD19 CAR T Cells to Deplete B Cells and Provide Therapeutic Benefit in SLE and RA Mouse Models Without Lymphodepletion
    Abstract Poster Presenter: Paul-Joseph Aspuria, PhD (he/him/his) – Synthekine
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0088: Profound B Cell Depletion and Repopulation with Predominantly Naïve B Cells in Non-Human Primates Achieved Through a Novel In Vivo CD8-Targeted Lipid Nanoparticle mRNA CAR
    Abstract Poster Presenter: Aric Frantz, PhD, DVM – Capstan Therapeutics
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0089: Single-Cell RNA Sequencing Outlines the Mechanisms of Vgll3-Driven Myofibroblasts Differentiation in Promoting Fibrosis in Cutaneous Lupus
    Abstract Poster Presenter: Mehrnaz Gharaee-Kermani, DVM, MPH, PhD – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0090: Parenchymal and Hematopoietic IFNγ Signaling Exhibits Dichotomous Effects in Murine Lupus
    Abstract Poster Presenter: Jeremy Tilstra, MD, PhD – University of Pittsburgh
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0091: Targeting Endothelial Dysfunction in Lupus Nephritis: Effect of Sepiapterin, a Drug That Restores Endothelial Nitric Oxide Synthase Function, in a Murine Model of Lupus Nephritis
    Abstract Poster Presenter: Soroush Moradi, MD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0092: A New Generation Mesenchymal Stromal Cell (MSC)-based Cell Therapy Using Design of Experiments Halts Pristane Induced Glomerulosclerosis
    Abstract Poster Presenter: Hulya Bukulmez, MD (she/her/hers) – MetroHealth Medical Center, Case Western Reserve University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0093: Overexpression of Epidermal Ifnk Promotes Systemic CD8+ T Cell Maturation After UV-exposure
    Abstract Poster Presenter: Benjamin Klein, MD – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0094: Small GTPase Rab4A Regulates Mouse Behavior Through Altered Serum Serotonin Levels and Microglial mTORC1 Activation in Lupus-prone B6.TC Mice
    Abstract Poster Presenter: Thomas Winans, PhD – SUNY Upstate Medical University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0095: Expansion of Brain T Cell Subsets Outside of the Choroid Plexus in Murine Models of Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
    Abstract Poster Presenter: Minjung Kim, MS – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0096: Simultaneous Contribution of Brain-Intrinsic and Peripheral Disease Mechanisms to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus (NPSLE)
    Abstract Poster Presenter: Carla Cuda, PhD – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0097: The Human Lupus TREX1 D18N Mutation Engineered in C. Elegans Leads to Cell Death. What Can We Learn About Lupus Using C. Elegans?
    Abstract Poster Presenter: Htay Htay Kyi, MD (she/her/hers) – Rutgers New Jersey Medical School
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0607: Plasma Proteomic Analysis Reveals Type I Interferon Blockade Effects of Anifrolumab in Lupus Nephritis: Insights from a Phase 2 Trial
    Abstract Poster Presenter: Andrea Fava, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0608: Systematic Analysis Demonstrates the Added Value of CB-CAPs to SLE Diagnosis in a Large Validation Cohort
    Abstract Poster Presenter: Andrew Concoff, MD – Exagen, Inc.
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0609: The Mediating Role of Trust in Usual Rheumatologists on the Relationship Between Multidimensional Health Literacy and Medication Adherence Among Japanese Systemic Lupus Erythematosus Patients
    Abstract Poster Presenter: Nao Oguro, MD, PhD – Showa University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0610: Clinical Evaluation on IFI44L Gene Methylation Detection for Diagnosis of Systemic Lupus Erythematosus by Methylation Sensitive High Resolution Melting (MS-HRM)
    Abstract Poster Presenter: liancheng lin, PhD – shenzhen YIAN medical research center.
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0611: Subclinical Atherosclerosis Is Associated with Future Cardiovascular Events in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Longitudinal Prospective Study
    Abstract Poster Presenter: Arthur Mageau, MD, PhD (he/him/his) – Université Paris Cité
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0612: Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI): Results from the Egyptian College of Rheumatology (ECR) Study Cohort
    Abstract Poster Presenter: Osman Hammam, MD – Department of Rheumatology and Rehabilitation, Faculty of Medicine, New Valley University, New Valley
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0613: Prediction of Spontaneous Abortion in Women with Systemic Lupus Erythematosus (SLE) Based on Machine Learning Model: Insights from the Egyptian College of Rheumatology (ECR)–SLE Cohort
    Abstract Poster Presenter: Osman Hammam, MD – Department of Rheumatology and Rehabilitation, Faculty of Medicine, New Valley University, New Valley
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0614: Bridging the Gap Between Patient's Perception on Quality of Life and Disease Activity and Damage in Systemic Lupus Erythematous Patient
    Abstract Poster Presenter: DAVID FERNÁNDEZ-FERNÁNDEZ, MD (he/him/his) – SERVIZO GALEGO DE SAÚDE
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0615: Socioeconomic Determinants of Lupus Hospitalization Outcomes: A Review of Current Knowledge and Analysis of the 2016-2019 NRD Database
    Abstract Poster Presenter: Akhila Arya P V, MD (she/her/hers) – Bridgeport Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0616: Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Victoria Delk, MD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0617: Hereditary C1q Deficiency Is Associated with Type 1 Interferon-pathway Activation and a High Risk of Central Nervous System Inflammation
    Abstract Poster Presenter: Clément Triaille, MD, PhD – Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0618: Comparison of Cell Type-Specific Polygenic Risk in Systemic Lupus Erythematosus Patient and Healthy Controls
    Abstract Poster Presenter: Liyoung Kim, MD (she/her/hers) – Boston Children's Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0619: Prevalence and Factors Predicting Hemophagocytic Lymphohistiocytosis in Hospitalized Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: OKEOGHENE AKPOIGBE, MS, MBBS – NYCHH- HARLEM
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0620: Clinical Efficacy and Patient-Reported Outcomes in Anti-Ro/Sjögren’s Syndrome–Related Antigen a Antibody–Positive Patients with Active SLE Treated WithDeucravacitinib in the Phase 2 PAISLEY Trial
    Abstract Poster Presenter: Benjamin A. Fisher, MD, MBBS – University of Birmingham
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0621: Predictive Parameters of Disease-related Damage Accrual in Patients with Systemic Lupus Erythematosus: A Machine Learning Analysis
    Abstract Poster Presenter: Omer Pamuk, MD – University Hospitals Cleveland Medical Center/ Case Western Reserve University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0622: Translation, Adaptation and Validation of the Brazilian-Portuguese Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) Version: Partial Results from a Single Centre
    Abstract Poster Presenter: Fabiana Moura, n/a – Universidade Federal de Minas Gerais
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0623: Select Patient Reported Outcome Measure Domains Enhance Immune Mediator Based Indexes That Inform Flare Risk and Disease Activity in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Melissa Munroe, MD, PhD – Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc.
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0624: Coexisting Tubulointerstitial Inflammation and Damage Is a Risk Factor for Chronic Kidney Disease in Patients with Lupus Nephritis
    Abstract Poster Presenter: Dong-Jin Park, MD, PhD – Chonnam National University Medical School and Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0625: Trends, Outcomes, and Predictors of Mortality in Patients with SLE Hospitalized for Influenza
    Abstract Poster Presenter: Asim Khanfar, MD – Rochester General Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0626: Impact of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) in Systemic Lupus Erythematosus Patients from the Almenara Lupus Cohort
    Abstract Poster Presenter: Manuel Ugarte-Gil, MD, MSc – Universidad Cientifica del Sur
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0627: Clinical Conditions Associated with Presence of a High-titer Antinuclear Antibody in Individuals Without Autoimmune Disease
    Abstract Poster Presenter: Matthew Chung, BS (he/him/his) – Vanderbilt University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0628: Genetic Determinants of Childhood Onset Systemic Lupus Erythematosus
    Abstract Poster Presenter: Meghan Nelson, DO – National Institutes of Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0629: Evaluating the Concordance Between SRI4 and BICLA Using Placebo Data from Randomized Controlled Trials of Patients with Active Systemic Lupus Erythematosus
    Abstract Poster Presenter: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0630: Lupus Lymphocyte Activation Score of Pathologic T and B Cell Phenotypes Increased in Patients at Risk of Systemic Lupus Erythematosus
    Abstract Poster Presenter: Alice Horisberger, MD – Lausanne University Hospital (CHUV)
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0631: Impact of Baseline Proteinuria Level on Long-term Outcomes in Lupus Nephritis
    Abstract Poster Presenter: Fadi Kharouf, MD – University Health Network and University of Toronto, Toronto, ON, Canada
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0632: Cutaneous Lupus Erythema and Scale Have Similar Six-month Trends Without Significant Impact from Race/ethnicity or Disease Subtype
    Abstract Poster Presenter: Tyler Cepica, BS – University of Texas Southwestern Medical School
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0633: Novel LINE-1 Reverse Transcriptase Inhibitors Can Suppress Type I Interferon Responses and Are Promising Therapeutics for Lupus
    Abstract Poster Presenter: Wenyan Miao, PhD – Rome Therapeutics
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0634: Clinical Relevance of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Predicting Lupus Outcomes: A 5-Year Longitudinal Cohort Study
    Abstract Poster Presenter: Hyemin Jeong, MD – Chonnam National University Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0635: Medical Record Natural Language Processing and Patient Biometric and Self-Reported Measures Inform an Artificial Intelligence Augmented Remote Care Management Strategy for Lupus Patients
    Abstract Poster Presenter: Gerald Lushington, PhD – Progentec Diagnostics, Inc
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0636: Evaluation of Clinical, Histological and Biomarker Response After Induction Treatment of Lupus Nephritis (LN)
    Abstract Poster Presenter: Emilia Sato, MD, PhD – Universidade Federal de Sao Paulo
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0637: Active Implementation of Low Disease Activity State as Treatment Endpoint in a Large Cohort of Adolescents and Young Adults with Childhood Onset Systemic Lupus Erythematosus
    Abstract Poster Presenter: Coziana Ciurtin, MD, PhD, FRCP – University College London
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0638: Soluble TNF RII in Lupus Nephritis as a Biomarker of Disease Activity and Treatment Response
    Abstract Poster Presenter: Ranjan Gupta, MD;DM – All India Institute of Medical Sciences
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0639: Delayed Diagnosis in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0640: 7000-Plex Proteomic Screen of Urine for Flare Monitoring and Treatment Response Biomarkers in Active Lupus Nephritis
    Abstract Poster Presenter: Chandra Mohan, MD;PhD – University of Houston
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0641: Predictive Validity of Coronary Artery Calcium Scoring in Low Risk Systemic Lupus Erythematous Patients
    Abstract Poster Presenter: Katie Chakrabarti, MD – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0642: Anti-Myxovirus Resistance Protein 1: A Novel Biomarker for Autoimmune Myositis and Interstitial Lung Disease in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Eugene Krustev, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0643: Using FDG PET Brain Scans and Deep Learning Analyses to Identify a Specific Network Correlated with Cognitive Impairment in SLE
    Abstract Poster Presenter: Meggan Mackay, MD;MS – Feinstein Institutes for Medical Research
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0644: Scoping Literature Review to Identify Candidate Domains for the SLE OMERACT Core Outcome Set
    Abstract Poster Presenter: Wils Nielsen, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0645: Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis
    Abstract Poster Presenter: Mark Russell, MBChB – King’s College London
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0646: Chart Audit of over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations
    Abstract Poster Presenter: Sawyer May, BS (he/him/his) – Spherix Global Insights
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0647: Clinical Associations and Outcomes of Pericarditis in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Pankti Mehta, MD, MBBS, DM – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0648: Prevalence of Pulmonary Complications Among Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta-analysis
    Abstract Poster Presenter: Athanasios Vassilopoulos, MD – Warren Alpert Medical School of Brown University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0649: Urinary Acetylated Albumin as a Biomarker of Nephritis in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Yeo-Jin Lee, MD – Asan medical center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0650: Tubulointerstitial Inflammation Predicts Tubular Atrophy, Fibrosis, and Renal Function Loss in Lupus Nephritis
    Abstract Poster Presenter: Yevgeniya Gartshteyn, MD, MS – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0651: Renal Survival and Mortality in Patients with Proliferative and Membranous Lupus Nephritis
    Abstract Poster Presenter: So-Young Bang, MD, PhD – Hanyang University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0652: Analysis of Relapses in a Single Center Cohort of Patients with Lupus Nephritis
    Abstract Poster Presenter: Ahmet Gul, MD – Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0653: Impact of Lupus Nephritis on Neuropsychiatric SLE Outcomes
    Abstract Poster Presenter: Pu Jun Fang, MD – National defense medical center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0654: Corneal Confocal Microscopy: An Ophthalmic Imaging Biomarker for Small Fiber Neuropathy in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Miral Gharib, MD, MRCP, MBBCH – hamad medical corporation
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0655: Relationship Between Patient-Reported Outcomes to Hospitalization in Patients Living with SLE: A Retrospective Cohort Study Utilizing the FORWARD Lupus Registry
    Abstract Poster Presenter: Minjee Park, MSc – Alira Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0656: Lupus Myocarditis: Clinical Characteristics, Cardiac Magnetic Resonance Imaging Findings and Outcomes
    Abstract Poster Presenter: Maria del Carmen Zamora Medina, MD – National Institute of Perinatology
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0657: Data-driven Bayesian Network Analysis for Predicting Difficult-to-treat (DTT) Lupus Nephritis
    Abstract Poster Presenter: Jagan Babu Kuduva Loganathan, Sr, MBBS, MD (he/him/his) – Jawaharlal Institute of Postgraduate Medical Education and Research
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0658: Zetomipzomib (KZR-616), a First-in-Class Selective Immunoproteasome Inhibitor, Demonstrated Improvements in SLE/LN Disease Measures and Biomarkers in Patients with Highly Active SLE or Nephrotic Range Proteinuria in the Open-label Phase 1b/2 MISSION Study
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0659: Obinutuzumab Benefits Patients with Active Lupus Nephritis Irrespective of Baseline Proteinuria Severity: A Post Hoc Analysis of a Phase II Trial
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0660: Hydroxychloroquine Users at Lower Risk of Kidney Function Decline in Lupus Nephritis
    Abstract Poster Presenter: Shivani Garg, MD,MS – University of Madison, School of Medicine and Public Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0661: Validity, Reliability and Responsiveness of Lupus Impact Tracker and LupusPRO: AURORA Trial
    Abstract Poster Presenter: Meenakshi Jolly, MD – Rush University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0662: Deucravacitinib, a First-in-Class, Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in SLE: Efficacy by Baseline Demographics and Disease Characteristics in the Phase 2 PAISLEY Trial
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0663: Treatment Patterns and the Prevalence of Kidney Biopsy-Confirmed LN in Patients with SLE and Proteinuria: A Multicenter Cohort Study
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0664: Impact of Hydroxychloroquine and Belimumab on Early Glucocorticoid Reduction in New-Onset Systemic Lupus Erythematosus: A Retrospective Analysis of Risk and Protective Factors
    Abstract Poster Presenter: Takehiro Nakai, MD – St. Luke's International Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0665: Belimumab Induces Early and Sustained Resolution of Lupus Thrombocytopenia and Lupus Arthritis
    Abstract Poster Presenter: Martin Aringer, MD (he/him/his) – University Medical Center and Faculty of Medicine TU Dresden
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0666: Interferon-stimulated Genes on Peripheral CD8+ T Cells of SLE Patients Were the Keys for Early Response to BAFF/APRIL-targeted Therapy
    Abstract Poster Presenter: Cuiling Fan, DO – Nanfang Hospital, Southern Medical University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0667: Early Introduction of Biologic Agents in Systemic Lupus Erythematosus Reduces Relapse and Glucocorticoid Maintenance Dose: A Cohort Study from the PLEAJURE J Registry
    Abstract Poster Presenter: Kohei Tsujimoto, MD, PhD – Osaka University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0668: There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY
    Abstract Poster Presenter: Kiera Brennan, MD (she/her/hers) – Albert Einstein College of Medicine/Montefiore Medical Center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0669: Efficacy of Belimumab in Systemic Lupus Erythematosus: A Single-Centre Retrospective Study
    Abstract Poster Presenter: Buddhika Jayaratna, Sr, MD, MBBS, MRCP – Guys & St Thomas NHS Foundation Trust
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0670: A Randomized, Open-Label, Phase III Trial Comparing Efficacy and Safety of Intravenous Cyclophosphamide, Mycophenolate Mofetil, or Tacrolimus as Induction Therapy in Lupus Nephritis
    Abstract Poster Presenter: Alekhya Amudalapalli, MD (she/her/hers) – IMS and SUM Hospital
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0671: Effect of Litifilimab on Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) Subcomponents and Physician Global Assessment–Skin (PGA–Skin) in Patients with Cutaneous Lupus Erythematosus (CLE) in a Phase 2 Study
    Abstract Poster Presenter: Victoria Werth, MD – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0672: Pharmacokinetics (PK), Effectiveness and Safety of Open-label (OL) Tofacitinib for the Treatment of Moderate to Severe Skin Involvement in Young Adults with SLE
    Abstract Poster Presenter: Ivanna Romankevych, MD, PhD – Danylo Halysky Lviv National Medical University
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0673: BCMA-CD19 Compound CAR-T (cCAR) Safely Provides a Complete Humoral Reset Eliminating All Autoantibodies Resulting in Long-term Medication-Free Complete Remission Among Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) Patients
    Abstract Poster Presenter: Greg Deener, BS – iCell Gene Therapeutics Inc.
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0674: Hydroxychloroquine Screening Adherence: Insights from Highmark Claims Data
    Abstract Poster Presenter: Tanmayee Bichile, MD – Allegheny Health Network
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0675: Hydroxychloroquine Induced Cardiomyopathy: A Biopsy Proven Case Series
    Abstract Poster Presenter: Swetapadma Tripathy, MD – Montefiore Medical Center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0676: Understanding the Patient Burden of Lupus: Insights from Multi-Faceted Ethnography Research
    Abstract Poster Presenter: Jeanette Andersen, MS, MA – Lupus Europe
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    1:00 PM – 2:30 PM Eastern Time
    16S54: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Omics
    Location: Ballroom B
    Abstract Moderator: Andras Perl, MD, PhD – SUNY
    Abstract Moderator: Susanna Proudman, MBBS – Royal Adelaide Hospital and University of Adelaide
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Saturday, Nov 16th
    1:00 PM – 1:15 PM Eastern Time
    0811: High-Throughput Proteomic Profiling of Longitudinal Serum Samples to Predict Treatment Response in Lupus Nephritis
    Location: Ballroom B
    Presenting Author: Joel Guthridge, PhD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    1:15 PM – 1:30 PM Eastern Time
    0812: A Human Gut Pathobiont Drives Platelet Activation with Microparticle Release and NETosis During Lupus Nephritis Flares
    Location: Ballroom B
    Presenting Author: Abhimanyu Amarnani, MD;PhD – New York University Grossman School of Medicine
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    1:30 PM – 1:45 PM Eastern Time
    0813: Investigating TASL, SLC15A4, & TLR7 Associated Risk SNPs in Systemic Lupus Erythematosus
    Location: Ballroom B
    Presenting Author: Christina Bruxvoort, PhD, BS, MSc – The University of Oklahoma Health Sciences Center
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    1:45 PM – 2:00 PM Eastern Time
    0814: Rare Variants of PAH Risk Genes Associate with a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension
    Location: Ballroom B
    Presenting Author: Mengtao Li, MD;PhD – Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    2:00 PM – 2:15 PM Eastern Time
    0815: Interferon-stimulated Gene Expression in Non-lesional Skin Is Similarly Elevated in Incomplete SLE and SLE
    Location: Ballroom B
    Presenting Author: Svenja Henning, MD – University of Groningen
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    2:15 PM – 2:30 PM Eastern Time
    0816: Distinct Transcript and Protein Dysregulation Patterns in Dermatomyositis and Systemic Lupus Erythematosus
    Location: Ballroom B
    Presenting Author: Sarfaraz Hasni, MD, MSc – National Institutes of Health
    Systemic lupus erythematosus (SLE)
  • Saturday, Nov 16th
    3:00 PM – 4:00 PM Eastern Time
    16S40: Dubois Memorial Lecture
    Location: Room 144ABC
    Moderator: Rashmi Dhital, MD – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Saturday, Nov 16th
    3:00 PM – 4:00 PM Eastern Time
    Building a More Equitable Future in Lupus Care and Outcomes
    Location: Room 144ABC
    Speaker: Candace Feldman, MD, MPH, ScD – Brigham and Women's Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Diagnosis, Manifestations, & Outcomes Poster II
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Treatment Poster II
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1483: Real World Data on Infections from the Indian SLE Inception Cohort for Research (INSPIRE): Spectrum and Risk Factors
    Abstract Poster Presenter: Amita Aggarwal, MD,MBBS,DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1484: A Retrospective Evaluation of Glucagon-like Peptide-1 Receptor Agonists in SLE Patients
    Abstract Poster Presenter: Philip Carlucci, MD – New York University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1485: Genetic Contributions to Systemic Lupus Erythematosus: Concordance Rates in California Twins
    Abstract Poster Presenter: Rashmi Dhital, MD – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1486: Cardiovascular Risk in Systemic Lupus Erythematosus: Carotid Ultrasonography Is Useful for the Re-stratification of Cardiovascular Risk Determined by Score2
    Abstract Poster Presenter: Cristina Corrales, MD – Rheumatology, Marques de Valdecilla University Hospital. IDIVAL
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1487: Pregnancy Outcome and Risk Factors Analysis in Patients with Systemic Lupus Erythematosus Complicated with Thrombocytopenia
    Abstract Poster Presenter: Fan Lian, PhD – First Affiliated Hospital of Sun Yat-sen University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1488: Clinical Utility and Performance of Anti-C1q Antibodies for Systemic Lupus Erythematosus: Comparative Analysis of Three Different Assays
    Abstract Poster Presenter: Mariana Gonzalez-Trevino, MD – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1489: Lupus Nephritis Clinical and Serological Responses at 12 Months: Implications for Repeat Biopsy, Intensified Immunosuppression or Additional Anti-proteinuric Therapy
    Abstract Poster Presenter: H Michael Belmont, MD, MACR – NYU School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1490: Multi-centered Clinical Validation of T Cell-bound C4d (TC4d) and T Cell Autoantibodies (TIgG and TIgM): Sensitive and Specific Biomarkers of SLE with Enhanced Accuracy Compared to Conventional SLE Tests
    Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1491: Self-Reported Cognitive Function Among Older Adults with Systemic Lupus Erythematosus (SLE) Compared to Older Adults with Other Rheumatic and Musculoskeletal Conditions
    Abstract Poster Presenter: Patti Katz, PhD – UCSF
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1492: Timing of SLEDAI-2K Item Improvements During the First Year of Intravenous Anifrolumab Treatment of Moderate to Severe SLE
    Abstract Poster Presenter: Ed Vital, n/a – Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1493: How Do Lupus Nephritis Patients Who Achieve Renal Remission Fare? A 3-year Comparison in Terms of GFR Decline
    Abstract Poster Presenter: Jorge Guerra Sayre, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1494: Trajectories of Disease Evolution upon Treatment Initiation in Systemic Lupus Erythematosus: Pooled Results from Three Randomized Clinical Trials of Belimumab
    Abstract Poster Presenter: Lorenzo Beretta, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1495: Real-World Reduction in Disease Flares and Oral Corticosteroid Use with Anifrolumab Therapy in Systemic Lupus Erythematosus: A Claims-Based Study
    Abstract Poster Presenter: Mawuena Binka, PhD, MPH – AstraZeneca
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1496: Dysregulated Serum Cytokines in Association with Clinical Manifestations in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Loqmane seridi, PhD – J&J
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1497: Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Justin Smith, BSc, MD, FRCPC (he/him/his) – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1498: Gender Disparities in Clinical Manifestations and Outcomes of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
    Abstract Poster Presenter: Mazen Allouni, MD – Case Western Reserve, University Hospitals, Cleveland Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1499: Outcome of Newly Onset SLE with Neuropsychiatric Symptoms and Its Clinical Features in Daily Clinical Practice: A Single Center Study
    Abstract Poster Presenter: Shuzo Sato, MD, PhD – Fukushima Medical University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1500: Work-Related Disability and Function in Systemic Lupus Erythematosus (SLE): Outcomes of an Exploratory Study from Different Canadian Centres
    Abstract Poster Presenter: Zahi Touma, MD,PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1501: Retrospective Cohort Study Identifying Pulmonary Complications in a Cohort of Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Jessica Johnson, BS – Cleveland Clinic Lerner College of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1502: The Systemic Lupus International Collaborating Clinics (SLICC) Frailty Index (SLICC-FI) Predicts Hospitalizations. Data from the Almenara Lupus Cohort
    Abstract Poster Presenter: Manuel Ugarte-Gil, MD, MSc – Universidad Cientifica del Sur
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1503: Social Connections Among Middle-Aged and Older Adults with Systemic Lupus Erythematosus: A Single Center Cross-Sectional Study
    Abstract Poster Presenter: Sarah Lieber, MD, MS (she/her/hers) – Hospital for Special Surgery
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1504: Novel Analytes Associated with Cognitive Impairment in Patients with Systemic Lupus Erythematosus: Serum S100A8/A9, MMP-9 and IL-6
    Abstract Poster Presenter: Emma Neary, MD – McGill University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1505: Incidence of Cardiovascular and Venous Thromboembolic Events in Four Autoantibody-defined Systemic Lupus Erythematosus Clusters
    Abstract Poster Presenter: Sara Ferrigno, MD – Department of Systems' Medicine, University of Rome Tor Vergata
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1506: Cognitive Impairment Prevalence and Most Affected Domains in Patients with SLE by the ACR Comprehensive Neuropsychological Battery
    Abstract Poster Presenter: Chrisanna Dobrowolski, MD,MS – Icahn School of Medicine at Mount Sinai
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1507: To Develop a Method for Estimating Interferon Signatures in SLE from Routine Clinical Laboratory Tests
    Abstract Poster Presenter: Yoshinobu Koyama, MD, PhD (he/him/his) – Japanese Red Cross Okayama Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1508: Clinical Characteristics and Prognosis of Late-onset Systemic Lupus Erythematosus in 305 Japanese Patients
    Abstract Poster Presenter: Yuko Shirota, MD;PhD – Tohoku University Hospital / Department of Hematology and Rheumatology
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1509: Validation of a Score for the Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus: Data from a Latin American Lupus Cohort
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1510: Impact of Active Lupus Nephritis on the Quality of Life of Patients from a Latin American Lupus Cohort
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1511: Lupus Nephritis and Response to Treatment in Latin America
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1512: Association Between the Systemic Immune Inflammatory Index (Sll) and All-cause Mortality in Critically Ill Patients with Rheumatoid Arthritis
    Abstract Poster Presenter: zhihan chen, MD – Fujian Provincial Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1513: Assessing Subjective Cognitive Impairment in a Cohort of Canadian Systemic Lupus Erythematosus Patients: Construct Validity of PDQ-20
    Abstract Poster Presenter: Omar Marzouk, BSc – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1514: Immunosenescent and Exhausted T Cells in Patients with Systemic Lupus Erythematosus and Cognitive Impairment
    Abstract Poster Presenter: Erik Cimé-Aké, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1515: Incidence and Predictors of Neuropsychiatric Lupus—a Contemporary Cohort Study Across the United States
    Abstract Poster Presenter: Yomaira Silva, MD – Mass General Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1516: Diagnostic Performance of Anti-ribosomal P Antibodies in Cerebrospinal Fluid of Neuropsychiatric Systemic Lupus Erythematosus with Diffuse Central Nervous System Manifestations. Experience in a Tertiary Center in Mexico
    Abstract Poster Presenter: Marlon Sandino, MD (he/him/his) – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1517: Diagnostic Performance of Anti-dsDNA Antibodies in Pleural, Ascitic and Pericardial Fluid for Lupus Serositis: Experience of a Tertiary Center in Mexico
    Abstract Poster Presenter: Marlon Sandino, MD (he/him/his) – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1518: Predictive Value of Chronic Histologic Changes in Lupus Nephritis
    Abstract Poster Presenter: Maria Cuellar-Gutierrez, MD – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1519: Incidence, Risk Factors, and Outcomes of Severe Lymphopenia in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Chunhui Chen, PhD, MBBS – New York Presbyterian Queens
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1520: The Influence of Trauma on Features of Type 2 SLE
    Abstract Poster Presenter: Jennifer Rogers, MD – Duke
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1521: Contemporary Lupus Nephritis Treatment and Outcomes Among Patients with Systemic Lupus Erythematosus in the United States
    Abstract Poster Presenter: Aakash Patel, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1522: Impact of Thrombocytopenia on In-hospital Mortality and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus: An Analysis of the National Inpatient Sample Database 2020
    Abstract Poster Presenter: Soziema Salia, MD, MPH – MedStar Health Baltimore
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1523: Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020
    Abstract Poster Presenter: Husam El Sharu, MD – East Carolina University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1524: Thrombocytopenia and Systemic Lupus Erythematosus: A Meta-analysis of Observational Studies
    Abstract Poster Presenter: Alexandre Matar, MD – MetroHealth
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1525: Early versus Late Lupus Nephritis: A Meta-analysis of Observational Studies
    Abstract Poster Presenter: Alexandre Matar, MD – MetroHealth
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1526: Utilizing Electronic Health Records to Identify Clinical Features of ANA-Positive Patients Imparting High Risk for Progression to Systemic Lupus Erythematosus
    Abstract Poster Presenter: Havell Markus, BS – Penn State College of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1527: Comparative Harms in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab or Belimumab: A Multicenter Cohort Study Using the TriNetX Research Network
    Abstract Poster Presenter: Hsin-Hua Chen, MD, PhD – Taichung Veterans General Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1528: Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: National Inpatient Sample Analysis
    Abstract Poster Presenter: Maria Emilia Romero Noboa, MD – University of Alabama at Birmingham
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1529: Systemic Lupus Erythematous and Neuromyelitis Optica Overlap and Risk of Infection in Hospitalized Patients
    Abstract Poster Presenter: Elizabeth Fagin, MD – Staten Island University Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1530: Belimumab-Treated Patients with Systemic Lupus Erythematosus Without Prior Immunosuppressant Use Have More Favorable Clinical Outcomes Than Those with Prior Use of an Immunosuppressant
    Abstract Poster Presenter: S. Sam Lim, MD,MPH – Emory University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1531: Prospective mRNA SARS-CoV-2 Additional Vaccination in Systemic Autoimmune Disease Patients on Immunosuppressive Medications in a Randomized Controlled Trial
    Abstract Poster Presenter: Judith James, MD,PhD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1532: Not yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance
    Abstract Poster Presenter: Sawyer May, BS (he/him/his) – Spherix Global Insights
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1533: Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, Effectively Depletes Low-Expressing CD20+ B Cells in Preclinical Models of Autoimmune Disease
    Abstract Poster Presenter: Racquel Domingo-Gonzalez, PhD – IGM Biosciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1534: Use and Safety of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients with Lupus Nephritis and Clinical Indications
    Abstract Poster Presenter: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1535: Variations in Tacrolimus Whole Blood Concentrations During Pregnancy and Its Implications for Therapeutic Drug Monitoring: A Systematic Review and Meta-analysis
    Abstract Poster Presenter: Evelyne Vinet, MD, PhD, FRCPC – McGill University Health Centre
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1536: Prescription Rates of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Lupus Nephritis: A Comparative Study Across Specialties
    Abstract Poster Presenter: JM JANSZ, MD – University of Illinois at Chicago
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1537: Discovery of VENT-03: A Novel Clinical cGAS Inhibitor for the Treatment of SLE and Other Autoimmune Diseases
    Abstract Poster Presenter: Kelly Pike, PhD – Ventus Therapeutics
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1538: Patient Reported Outcomes Analyses from AURORA 1 Clinical Trial: Lupus Impact Tracker and LupusPRO
    Abstract Poster Presenter: Meenakshi Jolly, MD – Rush University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1539: Effectiveness & Safety of Early versus Late Use of Rituximab in Extra-renal Lupus: Real World Experience from a Tertiary Care Centre
    Abstract Poster Presenter: JOHN KUMAR DAS, DM Rheumatology (he/him/his) – Christian Medical College
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1540: Project HOPE: HydrOxychloroquine Adherence ProjEct
    Abstract Poster Presenter: Meredith LiCalzi, BS – Frank H. Netter MD School of Medicine at Quinnipiac University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1541: Effect of Rituximab on Long-term Damage Acquisition in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Amanda Brito, MD – Instituto de Medicina Integral Professor Fernando Figueira
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1542: Efficacy and Safety Results from a Phase 2 Trial of Daxdilimab in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1543: Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
    Abstract Poster Presenter: Amit Saxena, MD;MSc – NYU School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1544: Comparison of Efficacy and Safety Between Belimumab and Telitacicept in the Treatment of Systemic Lupus Erythematosus
    Abstract Poster Presenter: ling lei, Chief physician (she/her/hers) – The First Affiliated Hospital of Guangxi Medical University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1545: Rates of Sustained Complete Renal Response with Long-term Use of Voclosporin in AURORA 2
    Abstract Poster Presenter: Ernie Yap, MD (he/him/his) – Aurinia Pharmaceuticals
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1546: Characteristics and Treatment Patterns of Patients with Lupus Nephritis: A Retrospective Claims Database Study in the USA
    Abstract Poster Presenter: Anisha M. Patel, PhD – Genentech, Inc.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1547: Hydroxychloroquine and Prednisone Use by Individuals Diagnosed with Systemic Lupus Erythematosus in the TriNetX Research Database
    Abstract Poster Presenter: Moises Narvaez, BS (he/him/his) – UT Southwestern
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1548: Anifrolumab in Systemic Lupus Erythematosus. Spanish National Registry in a Real-world Setting
    Abstract Poster Presenter: CARMEN SECADA GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1549: Prescribing Trends for Novel Treatments in Systemic Lupus from 2017 to 2022
    Abstract Poster Presenter: Celestine He, BA – Icahn School of Medicine at Mount Sinai
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1550: CD19 CAR T Cell Therapy Suppresses the Inflammatory Profile of Neutrophils in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Panagiotis Garantziotis, MD,PhD – Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1551: Efficacy of Belimumab on Different Phenotypes of Joint and Skin Manifestations of Systemic Lupus Erythematosus: Preliminary Data from a Multicenter, Nationwide, Cohort of Patients: The BElimumab in Real Life Setting Study-New Joint and Skin (BeRLISS-NeJS)
    Abstract Poster Presenter: Luca Iaccarino, PhD – University of Padua
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1552: Kinetics of Mucocutaneous and Musculoskeletal Responses to Deucravacitinibin Patients with Active SLE in the Phase 2 PAISLEY Trial
    Abstract Poster Presenter: Ronald Van Vollenhoven, MD, PhD – Amsterdam UMC
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1553: Safety, Pharmacokinetics, Clinical Efficacy and Exploratory Biomarker Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Enpatoran in Active Systemic and Cutaneous Lupus Erythematosus (SLE/CLE)
    Abstract Poster Presenter: Torsten Witte, MD – Dept of Rheumatology and Immunology
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1554: Belimumab Increases SLE Responder Index-4 Response Rates versus Placebo in Early Active Systemic Lupus Erythematosus: A Large Integrated Analysis of Belimumab Trials
    Abstract Poster Presenter: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1555: Sustained Functional Assessment of Chronic Illness Therapy–Fatigue Response in Patients with SLE Receiving Anifrolumab Alongside Standard Therapy
    Abstract Poster Presenter: Vibeke Strand, MD – Stanford University School of Medicine, Palo Alto CA
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1556: Efficacy and Safety of Anifrolumab Across Organ Domains of Systemic Lupus Erythematosus. A Systematic Review and Meta-Analysis
    Abstract Poster Presenter: Mohammad Taha, MBBS,MBBCH – cairo
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    11:30 AM – 12:30 PM Eastern Time
    MTP15A: Meet the Professor: Systemic Lupus Erythematosus
    Location: Room 148
    Seminar Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Sunday, Nov 17th
    1:00 PM – 2:30 PM Eastern Time
    17S56: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Biomarkers
    Location: Room 146AB
    Abstract Moderator: Yashaar Chaichian, MD – Stanford University
    Abstract Moderator: Konstantinos Tselios, MD, PhD – McMaster University
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Sunday, Nov 17th
    1:00 PM – 1:15 PM Eastern Time
    1683: 68Ga-FAPI PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis
    Location: Room 146AB
    Presenting Author: Hui Shi, M.D., Ph.D. – Department of Rheumatology and lmmunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    1:15 PM – 1:30 PM Eastern Time
    1684: Autoantibodies to Transcription Factor a Mitochondria Are Associated with Damage Accrual, Malignancy Risk and Mortality in SLE
    Location: Room 146AB
    Presenting Author: Eduardo Gomez-Banuelos, MD,PhD – The Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    1:30 PM – 1:45 PM Eastern Time
    1685: The Renal Activity Index for Lupus (RAIL) Identifies Active Renal Disease in SLE Patients and Its Longitudinal Score Associates with Achievement of Renal Responses in Lupus Nephritis
    Location: Room 146AB
    Presenting Author: Minal Aundhia, MD (she/her/hers) – Cincinnati Children's Hospital Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    1:45 PM – 2:00 PM Eastern Time
    1686: Urine Proteomics in Class II Lupus Nephritis Reveals Immune Activation and Pro-Fibrotic Signatures
    Location: Room 146AB
    Presenting Author: Jasmine Shwetar, -None- – New York School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    2:00 PM – 2:15 PM Eastern Time
    1687: IgG and IgA anti-LIN28A Outperform Anti-dsDNA and anti-Sm in Distinguishing SLE from Health and Other Autoimmune Diseases
    Location: Room 146AB
    Presenting Author: Ioannis Parodis, MD,PhD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    2:15 PM – 2:30 PM Eastern Time
    1688: Discovery and Validation of a New Classification of ANA-RMDs That Better Predict Long Term Outcomes Compared to Legacy Diagnoses
    Location: Room 146AB
    Presenting Author: Jack Arnold, MRCP – Leeds Institute of Rheumatic & Musculoskeletal Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    2:15 PM – 3:15 PM Eastern Time
    17S38: CARE to Test Your Knowledge: Lupus Nephritis
    Location: Hall D/E
    Moderator: Ashira Blazer, MD;MS – University of Maryland Baltimore
    Moderator: Amit Saxena, MD;MSc – NYU School of Medicine
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Sunday, Nov 17th
    2:15 PM – 3:15 PM Eastern Time
    CARE: Lupus Nephritis
    Location: Hall D/E
    Speaker: Maria Dall'Era, MD – UCSF
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:00 PM – 4:30 PM Eastern Time
    17S66: Abstracts: SLE – Treatment I: Cellular Therapy
    Location: Room 146AB
    Abstract Moderator: Megan Barber, MD, PhD – University of Calgary
    Abstract Moderator: Elena Massarotti, MD – Brigham and Women's Hospital
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Sunday, Nov 17th
    3:00 PM – 4:30 PM Eastern Time
    17S42: Crossing Enemy Lines: Lupus Autoantibodies Reactive to Brain Antigens
    Location: Room 102AB
    Moderator: Betty Diamond, MD – The Feinstein Institutes for Medical Research
    Moderator: Jacquelyn Nestor, MD,PhD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
     CME 1.5 hours
  • Sunday, Nov 17th
    3:00 PM – 3:15 PM Eastern Time
    1749: Safety and Long-term Efficacy of CD19-CAR T-cell Therapy in 30 Patients with Autoimmune Disease
    Location: Room 146AB
    Presenting Author: Melanie Hagen, MD,BSc (she/her/hers) – Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:00 PM – 3:30 PM Eastern Time
    An Overview of the Connection Between Autoantibodies and the Brain
    Location: Room 102AB
    Speaker: Judy Van de Water, PhD – University of California Davis
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:15 PM – 3:30 PM Eastern Time
    1750: Safety and Preliminary Efficacy of CD19 CAR-T Cell Treatment in Rheumatic Disease – Data from the First Part of the Phase I/II CASTLE Basket Study
    Location: Room 146AB
    Presenting Author: Georg Schett, MD (he/him/his) – Friedrich-Alexander-Universität Erlangen-Nürnberg
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:30 PM – 3:45 PM Eastern Time
    1751: Precision Targeting of Autoreactive 9G4 B Cells in Systemic Lupus Erythematosus Using Engineered Chimeric Antigen Receptor (CAR)- and Chimeric T Cell Receptor (cTCR)-T Cells
    Location: Room 146AB
    Presenting Author: Jin Liu, PhD, MBBS – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:30 PM – 4:00 PM Eastern Time
    Cross-Reactivity of Anti-P With Neuronal Surface P Antigen in Lupus
    Location: Room 102AB
    Speaker: Alfonso González, MD – Universidad San Sebastián
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    3:45 PM – 4:00 PM Eastern Time
    1752: T Cell-Engaging Bispecific Antibodies to Target Autoreactive 9G4 Idiotope B Cells in Systemic Lupus Erythematosus
    Location: Room 146AB
    Presenting Author: Maximilian F. Konig, MD – The Johns Hopkins University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    4:00 PM – 4:15 PM Eastern Time
    1753: A Phase 1, Multicenter, Open-Label Study to Establish the Preliminary Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of CC-97540 (BMS-986353), a CD19-directed CAR T Cell Therapy Manufactured Using a Next-generation Process, for Severe, Refractory Autoimmune Diseases
    Location: Room 146AB
    Presenting Author: Georg Schett, MD (he/him/his) – Friedrich-Alexander-Universität Erlangen-Nürnberg
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    4:00 PM – 4:30 PM Eastern Time
    Autoantibody-Mediated Neuronal Damage in Lupus
    Location: Room 102AB
    Speaker: Patricio Huerta, PhD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    4:15 PM – 4:30 PM Eastern Time
    1754: Comparing the Molecular Landscape of the CAR-T Cell and Rituximab Mediated Remission in Systemic Lupus Erythematosus
    Location: Room 146AB
    Presenting Author: Panagiotis Garantziotis, MD,PhD – Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 17th
    4:30 PM – 5:30 PM Eastern Time
    MTP15B: Meet the Professor: Systemic Lupus Erythematosus
    Location: Room 148
    Seminar Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    7:30 AM – 8:30 AM Eastern Time
    MTP17A: Meet the Professor: Lupus Nephritis
    Location: Room 154A
    Seminar Presenter: Maria Dall'Era, MD – UCSF
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    9:00 AM – 10:00 AM Eastern Time
    18M05: Implementation Science and Lupus: Effectively Bridging the Gap from Research to Practice
    Location: Room 102AB
    Moderator: Melissa French, MS (she/her/hers) – Lupus Foundation of America
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    9:00 AM – 10:00 AM Eastern Time
    18M10: XIST-ential: Sex-Biased Epigenetic Control of Systemic Lupus Erythematosus
    Location: Room 145AB
    Moderator: Christopher Scharer, PhD – Emory University
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    9:00 AM – 9:30 AM Eastern Time
    Implementation Science and Lupus: Opportunities for Increased Impact
    Location: Room 102AB
    Speaker: Sarah Gilman, MPH – Wayfinder Health Strategies
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    9:00 AM – 9:30 AM Eastern Time
    Loss of Epigenetic Modifications and Sex-Biased Gene Expression in SLE
    Location: Room 145AB
    Speaker: Montserrat Anguera, PhD – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    9:30 AM – 10:00 AM Eastern Time
    A Mixed-Methods Evaluation of Strategies to Embrace Living With Lupus Fearlessly (SELF): A Lupus Self-Management Program
    Location: Room 102AB
    Speaker: S. Sam Lim, MD,MPH – Emory University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    9:30 AM – 10:00 AM Eastern Time
    Xist Ribonucleoproteins Promote Female Sex-Biased Autoimmunity
    Location: Room 145AB
    Speaker: Diana Dou, PhD – Stanford
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:15 AM – 11:30 AM Eastern Time
    18M17: 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis
    Location: Room 146AB
    Moderator: Brad Rovin, MD – The Ohio State University
    Moderator: Ali Duarte-Garcia, MD, MSc – Mayo Clinic
    Systemic lupus erythematosus (SLE)
     CME 1.25 hours
  • Monday, Nov 18th
    10:15 AM – 10:30 AM Eastern Time
    ACR Lupus Nephritis Guideline Development and Key Recommendations
    Location: Room 146AB
    Speaker: Lisa Sammaritano, MD – Hospital for Special Surgery
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 10:45 AM Eastern Time
    Applying the Updated Guidelines to Various Classes of Lupus Nephritis
    Location: Room 146AB
    Speaker: Maria Dall'Era, MD – UCSF
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:45 AM – 11:00 AM Eastern Time
    Applying the Guidelines to Membraneous Lupus Nephritis
    Location: Room 146AB
    Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    11:00 AM – 11:15 AM Eastern Time
    Applying the Guidelines to Pediatric Lupus Nephritis
    Location: Room 146AB
    Speaker: Mary Beth Son, MD – Boston Children's Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    11:15 AM – 11:30 AM Eastern Time
    Panel Discussion & Questions
    Location: Room 146AB
    Panelist: Mary Beth Son, MD – Boston Children's Hospital
    Panelist: Lisa Sammaritano, MD – Hospital for Special Surgery
    Panelist: Maria Dall'Era, MD – UCSF
    Panelist: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Diagnosis, Manifestations, & Outcomes Poster III
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    SLE – Treatment Poster III
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1783: Deciphering the Roles of Mitochondrial-Related Genes and Ferroptosis in Systemic Lupus Erythematosus: Integrated Analysis for Diagnostic Biomarker Identification and Therapeutic Insights
    Abstract Poster Presenter: Yunfeng Dai, MMed – Fujian Medical University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1784: T-bet Expressing B Cells as a Putative Prognostic and Therapeutic Biomarker for Human SLE
    Abstract Poster Presenter: Christina Adamichou, MD,PhD – IPPOKRATEION GENERAL HOSPITAL OF THESSALONIKI
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1785: Comparative Immuno-Metabolomics Shows Singular Changes in Systemic Lupus Erythematosus Metabolic Phenotype Induced by T-Cell Activation
    Abstract Poster Presenter: Martin Stradner, MD (he/him/his) – Medical University of Graz
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1786: Select Immune Cell Dysregulation Identifies Clinically Quiescent Patients at Risk of Flare Who Stop Mycophenolate Mofetil While Continuing Hydroxychloroquine
    Abstract Poster Presenter: Christian Wright – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1787: Linking Transcriptomic Profiles of Kidney and Blood Samples Provides Insight into Identification of Lupus Nephritis
    Abstract Poster Presenter: Andrea Daamen, PhD – AMPEL BioSolutions
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1788: Memory B Cell Activation and Dysregulation in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Shady Younis, PhD – Stanford University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1789: Multi-omic Profiling Identifies Pathogenic Pro-inflammatory Human Monocytes/Macrophages in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Lais Osmani, MD – Yale
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1790: Response Gene to Complement-32 Expression Is Upregulated in Lupus T Cells and Promotes Th17 Differentiation
    Abstract Poster Presenter: Violeta Rus, MD (she/her/hers) – University of Maryland School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1791: A Transcriptomic Lupus Activity Signature Associates with Cardiovascular Function
    Abstract Poster Presenter: Matthew Muller, BA,MS – NYU
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1792: CD14+ Monocytes Demonstrate Subclinical Erythrocyte Uptake in Childhood Onset Systemic Lupus Erythematosus
    Abstract Poster Presenter: Lauren Robinson, MD (she/her/hers) – Hospital for Special Surgery
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1793: SLE Patient Serum and SLE-associated Danger Signals Impair Efferocytosis in Human Macrophages
    Abstract Poster Presenter: Rafael de Queiroz Prado, PhD (he/him/his) – AstraZeneca
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1794: Biobehavioral Basis and Outcomes of Cognitive Dysfunction in Childhood Systemic Lupus Erythematosus
    Abstract Poster Presenter: Hanne van der Heijden, MSc – Boston Children's Hospital Harvard Medical School
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1795: Immune Complexes-Mediated Activation of Neutrophils in Systemic Lupus Erythematosus Is Dependent on RNA Recognition by TLR8
    Abstract Poster Presenter: Ting Wang, MD;PhD – University of Washington
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1796: Kidney Hematopoietic Stem and Progenitor Cells Contribute to Immune Cell Development and Pathology in Lupus Nephritis
    Abstract Poster Presenter: Hansol Yi, MS – Ulsan university
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1797: Characterizing Memory T Cell Subsets Associated with SLE Etiopathogenesis
    Abstract Poster Presenter: Carol Nassar, BSc – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1798: CXCL6 Synthesized by Proximal Tubule Cells May Promote Fibrosis in Lupus Nephritis
    Abstract Poster Presenter: Philip Carlucci, MD – New York University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1799: In VitroEvidence for the Restoration of Glucocorticoid Sensitivity by Toll-Like Receptor 7 and 8 Inhibition in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Jia Xin Chow, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1800: WWC1 Regulates Type I Interferon Production Through Modulation of cGAS-STING Signaling in Keratinocytes
    Abstract Poster Presenter: Bin Xu, PhD – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1801: Inhibitory Effects of Dapirolizumab Pegol, a Monovalent Anti-CD40L PEG-Conjugated Antigen-Binding Fragment Lacking a Functional Fc Domain, on In Vitro T Follicular Helper/B Cell Interactions and Cytokine Production in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Anthony Shock, PhD – UCB
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1802: Heterogeneous Neutrophil Subsets Infiltrate Glomeruli of Lupus Nephritis Patients and Are Elevated in the Kidneys and Urine of Sunlight-induced Nephritis Flares
    Abstract Poster Presenter: Sladjana Skopelja-Gardner, PhD (she/her/hers) – Dartmouth Geisel School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1803: Genetics of eGFR Variability as a Proxy for Lupus Nephritis in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Linda Hiraki, MD,FRCPC,ScD – The Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1804: Investigating Adaptive Immune Receptor Repertoires by Deep Immune Cell Phenotyping in Preclinical Autoimmunity Development
    Abstract Poster Presenter: Aleksandra Bylinska, MSc – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1806: Bisphenol a Methylation Scores Associate with SLE and ClinicalSubphenotypes
    Abstract Poster Presenter: Holme Vestin, MS (he/him/his) – Uppsala university
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1807: Identification of HDAC Inhibitor Targeting Type I Interferon and B-cell Abnormalities in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Takehiro Hirayama, -None- – Osaka university
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1808: Not Only Type-I Interferon Regulated Genes Are Differentially Expressed in Circulating Monocytes from Active Lupus Nephritis Patients
    Abstract Poster Presenter: Gloria Vasquez, MD, PhD (she/her/hers) – Universidad de Antioquia
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1809: Melanocytes Are Driven Toward an Antigen Presentation Phenotype Through UV-Induced Keratinocyte Crosstalk and Exposure to Type I Interferons in Patients with Cutaneous Lupus Erythematosus
    Abstract Poster Presenter: Rezvan Moallemian, PhD (she/her/hers) – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1810: Modulation of Type I Interferon Signaling by Anifrolumab Alters the Spatial Immune Landscape in Cutaneous Lupus Erythematosus
    Abstract Poster Presenter: Ksenia Anufrieva, PhD (she/her/hers) – BWH
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1811: The Immune Map of Lupus Nephritis: A Spatially Resolved Kidney Proteomic Approach
    Abstract Poster Presenter: Andrea Fava, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1812: Glycosylation Changes as Non-Invasive Biomarkers for Lupus Nephritis Detection and Prognosis
    Abstract Poster Presenter: Aaron Angerstein, MD, PhD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    1813: Elucidating the Molecular Correlates of Treatment Response in Lupus Nephritis via Imaging Mass Cytometry Proteomics and Machine Learning
    Abstract Poster Presenter: Sen Hee Tay, PhD;MBBS;MRCP (he/him/his) – National University Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2370: Redefining Clinical Trial Inclusion Criteria Using Quality of Life in Cutaneous Lupus Erythematosus
    Abstract Poster Presenter: Daniella Faden, MPH – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2371: The Role of Intracytoplasmic Toll- Like Receptors (TLR) and MyD88 in B Cell Subsets as Renal Response Predictors in Patients with Lupus Nephritis
    Abstract Poster Presenter: Fabiola Cassiano-Quezada, MD – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2372: Incidence and Predictors of Recurrent Pericarditis in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Yoo Jin Kim, MD;MS (she/her/hers) – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2373: The Construction and Validation of Sub-phenotype-specific Genetic Risk Scores in Systemic Lupus Erythematosus: A Novel Approach Using Large-scale Biobank Data
    Abstract Poster Presenter: Dag Leonard, MD, PhD – Uppsala University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2374: Characteristics, Treatment Responses and Prognosis in a Single Center Cohort of SLE Patients with Thrombocytopenia
    Abstract Poster Presenter: Ahmet Gul, MD – Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2375: Can Damage Items Be Graded According to Severity in a Revised Organ Damage Index for Lupus?
    Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2376: Systemic Lupus Erythematosus Patients Exhibit Dynamic Changes in Disease-Associated Transcripts Following Total Knee or Total Hip Arthroplasty
    Abstract Poster Presenter: David Fernandez, MD, PhD – Hospital for Special Surgery
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2377: Impact of Neighborhood Area Deprivation Index on Outcomes in Lupus Patients in Bronx, NY
    Abstract Poster Presenter: Noa Schwartz, MD, MS – Albert Einstein College of Medicine/Montefiore Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2378: Is Urinary Protein-creatinine Relation Reliable for Diagnosis or Follow up of Lupus Nephritis?
    Abstract Poster Presenter: Ana Clara Freitas Ribeiro, MD – Rio de Janeiro State University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2379: Causal Proteomics-Assisted Machine Learning Model Enhances Flare Risk Prediction in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Liying Chen, MD – Second Clinical Medical College, Zhejiang Chinese Medical University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2380: Characterizing SLE Patients into Type 1 and Type 2 Disease States: Insights from a Single Lupus Cohort
    Abstract Poster Presenter: Angela Hu, MD, FRCPC – University of British Columbia
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2381: Clinical Characteristics, Readmission Rates, and Outcomes in Lupus Patients with and Without Nephritic Involvement: Analysis from a National Database
    Abstract Poster Presenter: Kishan Patel, MD – Riverside Community Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2382: Utility of Urinary Biomarkers to Predict Long-term Renal Outcomes in Lupus Nephritis
    Abstract Poster Presenter: Laura Patricia Whittall Garcia, MD – University Health Network
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2383: Outcomes of Systemic Lupus Erythematosus Hospitalizations: Insights from a Multinational Tertiary Center Experience
    Abstract Poster Presenter: Miral Gharib, MD, MRCP, MBBCH – hamad medical corporation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2384: Performance and Concordance of Two Different Methods of Detecting the Commonest Autoantibodies in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Ranjan Gupta, MD, DM – All India Institute of Medical Sciences
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2385: Increased Type I Interferon Inducible Genes Expression in the Peripheral Blood of Patients Presenting Cutaneous Lupus Erythematosus Manifestations
    Abstract Poster Presenter: ANASTASIA CHRONOPOULOU, MSc – National and Kapodistrian University of Athens
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2386: Landscape of Immune Cells and Autoimmunity in Systemic Lupus Erythematosus Patients with Obesity
    Abstract Poster Presenter: Alexandra Reese, MD – Ochsner Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2387: Biomarkers of Lupus Nephritis Are Less Predictive in APOL1 High Risk Genotype Lupus
    Abstract Poster Presenter: Madeline Alizadeh, PhD – University of Maryland School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2388: Racial/Ethnic Variation in Multimorbidity Risk and Accrual and Comorbid Conditions Among Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Katrina Williamson, MD, RhMSUS (she/her/hers) – University of Alabama Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2389: Choroidal Thickness in Active Lupus Nephritis
    Abstract Poster Presenter: Leticia Kolachinski Brandao, MD – Universidade de Sao Paulo
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2390: Anti-Sm Antibody Titers Vary During SLE Disease Course
    Abstract Poster Presenter: Faye Megaris, BS – CUNY School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2391: Identification of Patients with ANA Negative and Double Stranded DNA Positive: What Is the Significance in Daily Rheumatology Practise
    Abstract Poster Presenter: Güllü Sandal Uzun, MD (MD) – University College London
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2392: Clinical Characteristics and Outcomes of Systemic Lupus Erythematosus When Accompanying Myositis: A Retrospective Real-Life Study
    Abstract Poster Presenter: Güllü Sandal Uzun, MD (MD) – University College London
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2393: Demographic Differences in Trends of Systemic Lupus Erythematosus In-hospital Patient Outcomes
    Abstract Poster Presenter: Joan Morny, MBChB,MPH (she/her/hers) – Piedmont Athens Regional Internal Medicine Residency Program
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2394: Perioperative Stress Dose vs Therapeutic Dose Comparison: One-Month Postoperative Outcomes in Moderate and Major Surgeries for Systemic Lupus Erythematous and Rheumatoid Arthritis
    Abstract Poster Presenter: Alex Jakubiak, BS – Drexel University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2395: Validation Cohort of a Tool to Predict Proliferative Histological Class in Lupus Nephritis Based on Clinical and Laboratory Data - LUCAS Study (Lupus Nephritis Class Assessment System)
    Abstract Poster Presenter: Emilia Sato, MD, PhD – Universidade Federal de Sao Paulo
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2396: PROMISing Outcomes: Understanding the Concordance Between Provider-assessment and Patient-reported Disease Activity in SLE
    Abstract Poster Presenter: Anna Korogodina, MD – Beth Israel Deaconess Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2397: Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients
    Abstract Poster Presenter: ELENA GRAU GARCIA, PhD – HUP La Fe
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2398: The Relationship Between First-Trimester Maternal Serum 25-Hydroxyvitamin D and Maternal/Fetal Outcomes in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: wen zeng, MD (she/her/hers) – Guangxi Medical University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2399: Nationwide Analysis of Endovascular Thrombectomy in Ischemic Stroke Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Mortality and Healthcare Utilization
    Abstract Poster Presenter: Simran Bhimani, MD – The Wright Center for graduate medical education
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2400: Predicting Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: External Validation of the PROMISSE Model Using Multiple Independent Cohorts
    Abstract Poster Presenter: Melissa Fazzari, PhD – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2401: A Novel Modeling Approach to Elucidate the Role of Autoantibodies in Complement Activation in SLE
    Abstract Poster Presenter: David Pisetsky, MD,PhD – Duke University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2402: Belimumab Reduces Disease Flares versus Placebo in Adults with Early Active Systemic Lupus Erythematosus: Results of a Large Integrated Analysis
    Abstract Poster Presenter: Marta Mosca, MD;PhD – University of Pisa, Department of Clinical and Experimental Medicine - Rheumatology Unit
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2403: Health-related Quality of Life in Women with Systemic Lupus Erythematosus with Permanent Skin Damage and Its Association with Self-esteem and Symptoms of Depression and Anxiety – a Cross-sectional Study
    Abstract Poster Presenter: Fabiana Moura, PhD – Universidade Federal de Minas Gerais
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2404: Nailfold Dermoscopy: A Valuable Tool for Differentiating Dermatomyositis from Systemic Lupus Erythematosus
    Abstract Poster Presenter: Caroline Stone, BA – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2405: Chat-GPT Performance in Diagnosis of Rheumatological Diseases: A Comparison with Specialist's Opinion
    Abstract Poster Presenter: Lucas Gonçalves, -None- – Escola bahiana de Medicina e Saúde pública (EBMSP)
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2406: Neuropsychiatric Manifestations in Indian SLE Inception Cohort for Research: Prevalence, Predictors and Outcomes
    Abstract Poster Presenter: Amita Aggarwal, MD,MBBS,DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2407: Clinical Utility of Repeat Renal Biopsies in Lupus Nephritis: The NIH Chronicity Index at First Biopsy Predicts Future End Stage Renal Disease in a Large South Asian Cohort of SLE
    Abstract Poster Presenter: Rudrarpan Chatterjee, MD,MBBS,DM (he/him/his) – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2408: Impact of Pain and Fatigue on Quality of Life Among Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Amanda Eudy, PhD – Duke University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2409: Adherence to EULAR Recommendations and Sub Optimal Management of Systemic Lupus Erythematosus in a Network of Community-Based Rheumatology Practices in the United States
    Abstract Poster Presenter: Jeffrey R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2410: A Novel Treatment Response Measure for SLE Clinical Trials (TRM-SLE): Selection of Domains and Candidate Measures
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2411: Attainment of Complete Renal Response in Patients with Active Lupus Nephritis: A Multi-Center Cohort Study
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2412: Validation of Proposals for Definitions of Moderate and Severe Disease Activity in Systemic Lupus Erythematosus, Based on Data Gathered from the RELESSER-PROS Register Database
    Abstract Poster Presenter: Jaime Calvo Alén, n/a – Hospital Universitario de Araba
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2413: The Natural History of SLE Has Changed Since the 1970s
    Abstract Poster Presenter: Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2414: A Retrospective Comparative Analysis of Cardiovascular Risk Factors, Atherosclerotic Cardiovascular Disease and Statin Use as Secondary Prevention in a Cohort of Patients with Systemic Lupus Erythematosus versus Without Rheumatological Disease from a Single-Center Patient Registry
    Abstract Poster Presenter: Alma Aveytia Camacho, MD – Houston Methodist
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2415: Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network
    Abstract Poster Presenter: Nehad Soloman, MD – Arizona Arthritis & Rheumatology Associates, P.C.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2416: The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort
    Abstract Poster Presenter: Guillermo Pons-Estel, MD,PhD – CREAR
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2417: Frequency and Associated Factors of Herpes Zoster Infection in Systemic Lupus Erythematosus Patients from Latin-America
    Abstract Poster Presenter: Guillermo Pons-Estel, n/a – Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2418: Identification of Co-expressed Molecular Markers That Predict Risk of Severe Flare in Patients with Systemic Lupus Erythematosus (SLE)
    Abstract Poster Presenter: Matthew Linnik, PhD – Eli Lilly
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2419: Clinical and Patient-reported Outcomes in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS) US Data
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2420: Blood Transcriptome Analysis Reveals Enhanced B Cell and Complement Cascade Signatures in Patients with Major Neuropsychiatric Systemic Lupus Erythematosus
    Abstract Poster Presenter: Dionysis Nikolopoulos, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2421: Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network
    Abstract Poster Presenter: Mariana Gonzalez-Trevino, MD – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2422: Development of a Multiplexed-engineered, Off-the-shelf CAR NK Cell with Unique Multi-Pathogenic Cell Targeting Capacity for the Treatment of Autoimmune Diseases in the Absence of Conditioning Chemotherapy
    Abstract Poster Presenter: Lilly Wong, PhD – Fate Therapeutics, Inc.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2423: Associations Between Cytometric Interferon Signature and Clinical Response in a Cohort of Anifrolumab-treated Patients with Lupus
    Abstract Poster Presenter: Alice Horisberger, MD – Lausanne University Hospital (CHUV)
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2424: Anifrolumab Effects on Response to Influenza Vaccine in SLE
    Abstract Poster Presenter: Cristina Arriens, MD, FACR (she/her/hers) – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2425: Ianalumab Induced Durable Depletion of Circulating B Cell Subsets and Associated Changes in B Cell and Neutrophil Transcriptomic and Proteomic Profiles in Patients with Systemic Lupus Erythematosus: 52-Week Treatment Results from a Phase 2 Trial
    Abstract Poster Presenter: Thomas Dörner, MD – Charite Universitätsmedizin Berlin, Germany and DRFZ, Berlin
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2426: Multi-OMICs Analysis Including Lipidomics to Correlate Baseline OMICs Profiles with Disease Activity and Response to Different Immunomodulatory Treatments in Patients with Systemic Lupus Erythematosus - An Exploratory Pilot Study Using a Multi-OMICs Approach
    Abstract Poster Presenter: Frank Behrens, MD – Rheumatology & Fraunhofer TMP Goethe University Frankfurt, Germany
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2427: Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Induces Multicompartmental B Cell Depletion in Peripheral Blood, Bone Marrow and Lymph Nodes of Systemic Lupus Erythematosus
    Abstract Poster Presenter: Ioanna Minopoulou, MD,MSc – Universitätsmedizin Charite Berlin
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2428: Vitamin-D Effect on SLE- Scoping Review
    Abstract Poster Presenter: Joud Enabi, MD – TTUHSC
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2429: Impact of Hydroxychloroquine Level on ECG QTC Interval in Patients with Rheumatic Systemic Autoimmune Diseases: A Real-life Study
    Abstract Poster Presenter: Carmen Raya-Santos, Sr, MD (she/her/hers) – Hospital Marina Baixa
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2430: Dapirolizumab Pegol Impacts Important Immunologic Pathways in Systemic Lupus Erythematosus: Pharmacodynamic Analysis of T Cell and Antigen Presenting Cell Pathways from a Phase 2b Trial
    Abstract Poster Presenter: Ania Skowera, n/a – UCB Pharma
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2431: DORIS Remission in Patients with SLE Treated with Anifrolumab: Post Hoc Analysis from TULIP-1 and TULIP-2 Trials in Patents with No Reported History of Prior Immunosuppressant Use
    Abstract Poster Presenter: Andrea Doria, n/a – University of Padova
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2432: In Vitro and In Vivo Evidence of the Steroid-Sparing Potential of Afimetoran, an Equipotent Toll-Like Receptor 7/8 Dual Antagonist
    Abstract Poster Presenter: ALARIC DYCKMAN, PhD – Bristol Myers Squibb
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2433: Sequential Pneumococcal Vaccination in SLE: Immunogenicity, Side Effects and Comparison with PPSV23 Vaccination
    Abstract Poster Presenter: Amita Aggarwal, MD,MBBS,DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2434: ESK-001, an Allosteric TYK2 Inhibitor, Maximally Suppresses Type 1 Interferon, a Therapeutic Pathway Central to SLE and CLE
    Abstract Poster Presenter: Nicole Narayan, PhD (she/her/hers) – Alumis
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2435: Attainment of Remission, Use of Immunomodulatory/suppressive Agents and Gradual Dose Tapering May Facilitate Flare-free Withdrawal of Glucocorticoids in Patients with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Prodromos Sidiropoulos, MD – University of Crete, Laboratory of Rheumatology, Autoimmunity and Inflammation. University Hospital, Rheumatology, Clinical Immunology. Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2436: Characterization of RO7507062, a CD19-Targeting T-Cell Bispecific Antibody (CD19TCB), and Design of Its Ongoing Phase 1 Trial in Systemic Lupus Erythematosus
    Abstract Poster Presenter: Franz Schuler, PhD – F. Hoffmann-La Roche Ltd.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2437: Aryl Hydrocarbon Receptor as an Intrinsic Novel Checkpoint That Inhibits TLR7-induced B-cell Activation in SLE
    Abstract Poster Presenter: John D. Mountz, MD, PhD – University Alabama Birmingham
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2438: Reduction in Oral Corticosteroid Use During Anifrolumab Therapy: Observations from a Real-world Cohort of Adults with Systemic Lupus Erythematosus
    Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2439: Preliminary Analysis of Open-Label Dose-Titration Phase of SLE Treatment with N-Acetylcysteine (SNAC) Shows Evidence for Potential Improvement of SLEDAI, BILAG, ADHD and Fatigue Scores in Patients with Active SLE
    Abstract Poster Presenter: Andras Perl, MD, PhD – SUNY
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2440: Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient’s Characteristics
    Abstract Poster Presenter: Irene Carrión-Barberà, MD – Hospital del Mar
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:00 PM – 2:30 PM Eastern Time
    18M58: Abstracts: SLE – Animal Models
    Location: Room 152B
    Abstract Moderator: Carla Cuda, PhD – Northwestern University
    Abstract Moderator: Paul Hoover, MD, PhD – Brigham and Women's Hospital
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    1:00 PM – 2:30 PM Eastern Time
    18M59: Abstracts: SLE – Treatment II: Non-Cellular Lupus Therapeutics
    Location: Room 146AB
    Abstract Moderator: Diane Kamen, MD, MS – Medical University of South Carolina
    Abstract Moderator: Stephanie Keeling, MD – University of Alberta
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    1:00 PM – 1:15 PM Eastern Time
    2545: Phosphodiesterase 1B Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation
    Location: Room 152B
    Presenting Author: Shuhei Takeyama, MD – Hokkaido University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:00 PM – 1:15 PM Eastern Time
    2575: Can Immunosuppressive Therapy Be Safely Discontinued in Patients with Lupus Nephritis?
    Location: Room 146AB
    Presenting Author: Paola Vidal Montal, -None- – Bellvitge University Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:15 PM – 1:30 PM Eastern Time
    2546: Lipocalin-2 Drives Neuropsychiatric and Cutaneous SLE Through Regulation of Immune Cell Recruitment in Target Organs
    Location: Room 152B
    Presenting Author: Sayra Garcia, MS;BS – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:15 PM – 1:30 PM Eastern Time
    2576: Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
    Location: Room 146AB
    Presenting Author: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:30 PM – 1:45 PM Eastern Time
    2547: Neurophysiological Phenotypes Are Uncoupled from Toll-like Receptor-Mediated Peripheral Disease in a Mouse Model of Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
    Location: Room 152B
    Presenting Author: Cecilia Stumpf, BA – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:30 PM – 1:45 PM Eastern Time
    2577: Efficacy and Safety of ABBV-599 (Elsubrutinib and Upadacitinib Combination) and Upadacitinib Monotherapy for the Treatment of Systemic Lupus Erythematosus: Results Through 104 Weeks in a Long-Term Extension Study
    Location: Room 146AB
    Presenting Author: Joan Merrill, MD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:45 PM – 2:00 PM Eastern Time
    2548: NADPH Oxidase in B Cells and Macrophages Protects Against Murine Lupus by Regulation of TLR7
    Location: Room 152B
    Presenting Author: Rachael Gordon, MD, PhD (she/her/hers) – University of Pittsburgh
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    1:45 PM – 2:00 PM Eastern Time
    2578: Safety, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptor 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase1/2 Study in Systemic Lupus Erythematosus
    Location: Room 146AB
    Presenting Author: Yoshiya Tanaka, MD, PhD – University of Occupational and Environmental Health, Japan
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:00 PM – 2:15 PM Eastern Time
    2549: VISTA Deficiency Alters the Skin Immune Cell Composition and Confers Skin Sensitivity to UV Light
    Location: Room 152B
    Presenting Author: Zachary Peters, BA (he/him/his) – Dartmouth College
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:00 PM – 2:15 PM Eastern Time
    2579: Risk of End-Stage Renal Disease Among Patients with Lupus Nephritis on GLP-1 Receptor Agonists: A Retrospective Cohort Study
    Location: Room 146AB
    Presenting Author: Anna-Kay Palmer, MD, MBBS – Albert Einstein Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:15 PM – 2:30 PM Eastern Time
    2550: Infiltrating and Resident Macrophages in Lupus Nephritis: Scar Associated Macrophage Phagocytic Dysfunction and Fibroblast Activation
    Location: Room 152B
    Presenting Author: Chirag Raparia, MS, BS – Donald and Barbara Zucker School of Medicine At Hofstra/Northwell
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:15 PM – 2:30 PM Eastern Time
    2580: Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study
    Location: Room 146AB
    Presenting Author: Eduardo Mysler, MD – Organizacion Medica de Investigacion, Buenos Aires, AR
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:15 PM – 3:15 PM Eastern Time
    18M40: Great Minds Think About CNS Lupus
    Location: Ballroom A
    Moderator: May Choi, MD, FRCPC, MPH – University of Calgary
    Moderator: Cynthia Aranow, MD – Feinstein Institutes for Medical Research
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    2:15 PM – 2:35 PM Eastern Time
    Unraveling the Pathogenesis of CNS Lupus
    Location: Ballroom A
    Speaker: Betty Diamond, MD – The Feinstein Institutes for Medical Research
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:35 PM – 2:55 PM Eastern Time
    Uncovering the Clues to CNS Lupus
    Location: Ballroom A
    Speaker: Susanne Benseler, MD, PhD, FRCPC – Childrens Health Ireland
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    2:55 PM – 3:15 PM Eastern Time
    Utilizing Novel Treatments in CNS Lupus
    Location: Ballroom A
    Speaker: Zahi Touma, MD,PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:00 PM – 4:30 PM Eastern Time
    18M68: Abstracts: SLE – Etiology & Pathogenesis
    Location: Room 152B
    Abstract Moderator: Roberto Caricchio, MD – University of Massachusetts Chan Medical School
    Abstract Moderator: Melissa Cunningham, MD, PhD – Medical University of SC
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Monday, Nov 18th
    3:00 PM – 3:15 PM Eastern Time
    2599: Xist Deletion in B Cells Results in Systemic Lupus Erythematosus Phenotypes
    Location: Room 152B
    Presenting Author: Claudia Lovell, BA – Perelman School of Medicine at the University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:15 PM – 3:30 PM Eastern Time
    2600: Repression of the Aryl-hydrocarbon Receptor Prevents Oxidative Stress and Ferroptosis of Intestinal γδT Cells and Alleviates Systemic Lupus Erythematosus
    Location: Room 152B
    Presenting Author: Qiaolin Wang, PhD – Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:30 PM – 3:45 PM Eastern Time
    2601: Platelets Specifically Interact with Remigrating Neutrophils and Promote Immunogenic Cellular Death in Systemic Lupus
    Location: Room 152B
    Presenting Author: Marc Scherlinger, MD,PhD – Strasbourg University Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:45 PM – 4:00 PM Eastern Time
    2602: Genetics of Sex Dimorphism in Clinical Manifestations of Systemic Lupus Erythematosus
    Location: Room 152B
    Presenting Author: Caseng Zhang, -None- (he/him/his) – University of Ottawa
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    4:00 PM – 4:15 PM Eastern Time
    2603: A Human Lupus Gut Pathobiont Accelerates Systemic Inflammation, Autoantibody Production and T Cell Dysregulation
    Location: Room 152B
    Presenting Author: Gregg Silverman, MD – NYU Grossman School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    4:15 PM – 4:30 PM Eastern Time
    2604: Altered Expression of Ecto-5'-Nucleotidase (NT5E) in SLE Patients Based on Disease-associated Genotype
    Location: Room 152B
    Presenting Author: Mikhail Olferiev, MD – Hospital for Special Surgery
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:30 PM – 4:30 PM Eastern Time
    18M47: Cutting-Edge Understanding and Approach to Lupus Arthritis
    Location: Room 102AB
    Moderator: Ali Duarte-Garcia, MD, MSc – Mayo Clinic
    Moderator: Jennifer Grossman, MD – UCLA
    Systemic lupus erythematosus (SLE)
     CME 1 hours
  • Monday, Nov 18th
    3:30 PM – 3:50 PM Eastern Time
    Evaluating Lupus Arthritis: Novel Imaging Techniques
    Location: Room 102AB
    Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    3:50 PM – 4:10 PM Eastern Time
    Current Understanding of the Pathophysiology of Lupus Arthritis: How and Why Does It Differ From That of RA?
    Location: Room 102AB
    Speaker: Vivianne Malmström, PhD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 18th
    4:10 PM – 4:30 PM Eastern Time
    Treatment of Lupus Arthritis in 2024
    Location: Room 102AB
    Speaker: Kenneth Kalunian, n/a – University of California San Diego
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    11:00 AM – 12:30 PM Eastern Time
    19T15: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Targets, Outcomes & Comorbidity
    Location: Room 147AB
    Abstract Moderator: Anca Askanase, MD, MPH – Columbia University Medical Center
    Abstract Moderator: Fotios Koumpouras, MD – Yale School of Medicine
    Systemic lupus erythematosus (SLE)
     CME 0 hours
  • Tuesday, Nov 19th
    11:00 AM – 11:15 AM Eastern Time
    2677: N-Acetylcysteine Blocks the Mechanistic Target of Rapamycin in Pro-Inflammatory Effector-Memory CD4 and CD8 T Cells Re-Expressing CD45RA in Patients with Active Systemic Lupus Erythematosus
    Location: Room 147AB
    Presenting Author: Joy Park, BA – Upstate Medical University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    11:15 AM – 11:30 AM Eastern Time
    2678: History of Cutaneous Lupus Promotes Blood and Skin Interferon Signatures in SLE Patients
    Location: Room 147AB
    Presenting Author: Svenja Henning, MD – University of Groningen
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    11:30 AM – 11:45 AM Eastern Time
    2679: Predictors of Fracture in SLE: A Longitudinal Cohort Study
    Location: Room 147AB
    Presenting Author: Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    11:45 AM – 12:00 PM Eastern Time
    2680: Thrombocytopenia in Patients with Systemic Lupus ErythematosusReal-World Data Based on a Nationwide Database, RISE
    Location: Room 147AB
    Presenting Author: Omer Pamuk, MD – University Hospitals Cleveland Medical Center/ Case Western Reserve University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    12:00 PM – 12:15 PM Eastern Time
    2681: Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021
    Location: Room 147AB
    Presenting Author: Ami Vyas, PhD – University of Rhode Island
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 19th
    12:15 PM – 12:30 PM Eastern Time
    2682: The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort
    Location: Room 147AB
    Presenting Author: Ann E. Clarke, MD, MSc – University of Calgary
    Systemic lupus erythematosus (SLE)